Dual inhibitors of MET and VEGF for the treatment of castration-resistant prostate cancer and osteoblastic bone metastases

• 收藏
• 分享

专利权人:

Inc.;Exelixis

发明人:

Smith, David,Hussain, Maha

申请号：

AU2016204747

公开号：

AU2016204747A1

申请日:

2016.07.08

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016204747A120160728.pdf#####Abstract This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF. 39WO 2012/044572 PCT/US201 1/053233 3/3 Patient 3 Baseline Week 6 Week 12 B 200 1 a AP 20 S16,20. S 0 00 1 4M 20 0 -2 0 24 8 10 12 14 16 18 20 Weeks on Study HIG. 3 96959513

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/